Sciclone Pharmaceuticals, Inc. (SCLN) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Price: $11.15 --0%
Financial Fact:
Interest and investment income: 270K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Interest and investment income: 270K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) reported Q2 EPS of $0.20, $0.10 better than the analyst estimate of $0.10. Revenue for the quarter came in at $32.5 million versus the consensus estimate of $33.4 million.
For earnings history and earnings-related data on Sciclone Pharmaceuticals, Inc. (SCLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Cisco rating cut at HSBC as analyst sees a lack of catalysts
- Optimum Communications gets NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
